Clinical Trials Logo

Recurrent Meningiomas clinical trials

View clinical trials related to Recurrent Meningiomas.

Filter by:
  • None
  • Page 1

NCT ID: NCT02333565 Recruiting - Clinical trials for Resistant Meningiomas

Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas

Start date: January 2015
Phase: Phase 2
Study type: Interventional

To determine if combination of everolimus and octreotide exert an anti-tumoral activity in recurrent and/or aggressive meningiomas growth with limited adverse effects.